XML 31 R5.htm IDEA: XBRL DOCUMENT  v2.3.0.11
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
6 Months Ended
Jun. 30, 2011
Jun. 30, 2010
CASH FLOWS FROM OPERATING ACTIVITIES    
Net loss $ (5,755,533) $ (5,721,905)
Adjustments to reconcile net loss to net cash used by operating activities    
Amortization 153,378 153,379
Accrued interest 166,618 460,125
Depreciation 12,481 379,934
Change in allowance for doubtful accounts 19,751 9,007
Gain on sale of property and equipment   (2,065)
Stock-based compensation 300,210 937,700
Extinguishment of debt 1,318,781  
Changes in assets - (increase)/decrease    
Accounts receivable - trade (25,045) (30,724)
Inventory 15,366 45,045
Prepaid expenses (28,035) (11,685)
Due from Pulse Veterinary Technologies, LLC (53,619) (23,224)
Other assets (391) 349
Assets held for sale   2,516
Changes in liabilities - increase/(decrease)    
Accounts payable (221,520) 747,501
Accrued employee compensation (786,173) 299,266
Accrued expenses (117,316) (252,669)
Interest payable, related parties (2,009)  
NET CASH USED BY OPERATING ACTIVITIES (5,003,056) (3,007,450)
CASH FLOWS FROM INVESTING ACTIVITIES    
Proceeds from sale of property and equipment   2,500
Purchase of property and equipment (21,425)  
NET CASH PROVIDED (USED) BY INVESTING ACTIVITIES (21,425) 2,500
CASH FLOWS FROM FINANCING ACTIVITIES    
Proceeds from private placement 8,467,121  
Proceeds from unit options exercised, related parties 2,463,008  
Proceeds from unit options exercised 1,437,326  
Proceeds from promissory notes, related parties   1,500,000
NET CASH PROVIDED BY FINANCING ACTIVITIES 12,367,455 1,500,000
FOREIGN CURRENCY TRANSLATION ADJUSTMENTS 13,288 (4,161)
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS 7,356,262 (1,509,111)
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD 417,457 1,786,369
SUPPLEMENTAL INFORMATION    
Cash paid for interest 161,935  
NON-CASH INVESTING AND FINANCING ACTIVITIES    
Capital stock issued in exchange for notes payable, related parties (Notes 4 and 11) 4,413,908  
CASH AND CASH EQUIVALENTS, END OF PERIOD $ 7,773,719 $ 277,258